Dr. Susan Kahn honoured for a lifetime of achievement in thrombosis medicine
Dr. Kahn will receive a 2026 Esteemed Career Award from the International Society on Thrombosis and Haemostasis.
Dr. Susan Kahn renewed as Tier 1 Canada Research Chair in Venous Thromboembolism
Dr. Susan Kahn, a Senior Investigator in the Lady Davis Institute, has been renewed as a Tier 1 Canada Research Chair in Venous Thromboembolism.
Targeting venous thromboembolism through protein manipulation
The potential of manipulating a particular protein is being explored as a possible alternative to blood thinners, which are the standard of care for venous thromboembolism, but whose association with severe bleeding makes blood thinners an imperfect remedy.